Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 1.53 is 23% below its 5-year average of 1.98, near the low end of its 5-year range (1.43–2.50).
As of the fiscal period ended Friday, July 3, 2026. 9.95% below its 12-month average of 1.69.
Reported quarterly quick ratio; no daily interpolation. Q3 FY2026 (2026-07-03): 1.53.
QUICK RATIO (ACID-TEST)
1.53
QUICK RATIO (ACID-TEST) AVG TTM
1.69
QUICK RATIO (ACID-TEST) AVG 3Y
2.02
QUICK RATIO (ACID-TEST) AVG 5Y
1.98
QUICK RATIO (ACID-TEST) AVG 10Y
1.72
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
-9.95%
CURRENT VS 3Y AVG
-24.58%
CURRENT VS 5Y AVG
-22.78%
CURRENT VS 10Y AVG
-11.30%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.35
median of 871 covered companies
CURRENT VS SECTOR MEDIAN
-54.44%
vs the sector median at left
Varex Imaging Corporation
Market Cap
$778.24M
Quick Ratio (Acid-Test)
1.53
TTM Avg
1.69
3Y Avg
2.02
5Y Avg
1.98
Market Cap
$781.97M
Quick Ratio (Acid-Test)
1.38
TTM Avg
2.71
3Y Avg
3.18
5Y Avg
5.09
Market Cap
$772.90M
Quick Ratio (Acid-Test)
13.29
TTM Avg
5.16
3Y Avg
5.49
5Y Avg
4.89
Market Cap
$786.39M
Quick Ratio (Acid-Test)
0.98
TTM Avg
0.95
3Y Avg
0.97
5Y Avg
0.95
Market Cap
$782.66M
Quick Ratio (Acid-Test)
5.16
TTM Avg
4.89
3Y Avg
3.82
5Y Avg
4.31
Market Cap
$763.35M
Quick Ratio (Acid-Test)
9.39
TTM Avg
11.79
3Y Avg
11.79
5Y Avg
11.79
Market Cap
$759.25M
Quick Ratio (Acid-Test)
1.52
TTM Avg
0.88
3Y Avg
1.36
5Y Avg
2.75
Market Cap
$800.49M
Quick Ratio (Acid-Test)
3.86
TTM Avg
4.02
3Y Avg
3.56
5Y Avg
3.80
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Varex Imaging Corporation (VREX) | $778.24M | 1.53 | 1.69 | 2.02 | 1.98 |
| Sana Biotechnology, Inc. (SANA)vs › | $781.97M | 1.38 | 2.71 | 3.18 | 5.09 |
| Lexicon Pharmaceuticals, Inc. (LXRX)vs › | $772.90M | 13.29 | 5.16 | 5.49 | 4.89 |
| AdaptHealth Corp. (AHCO)vs › | $786.39M | 0.98 | 0.95 | 0.97 | 0.95 |
| Geron Corporation (GERN)vs › | $782.66M | 5.16 | 4.89 | 3.82 | 4.31 |
| Attovia Therapeutics, Inc. (ATTO)vs › | $763.35M | 9.39 | 11.79 | 11.79 | 11.79 |
| Mesa Laboratories, Inc. (MLAB)vs › | $759.25M | 1.52 | 0.88 | 1.36 | 2.75 |
| Gyre Therapeutics, Inc. (GYRE)vs › | $800.49M | 3.86 | 4.02 | 3.56 | 3.80 |
| Apnimed, Inc. (APMD)vs › | $750.67M | N/A | N/A | N/A | N/A |
| InMode Ltd. (INMD)vs › | $803.87M | 7.28 | 9.00 | 9.42 | 9.03 |
Quick Ratio
1.53
Excludes inventory
Current Ratio
3.38
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-07-03 | 1.53 |
| 2026-04-03 | 1.43 |
| 2026-01-02 | 1.87 |
| 2025-10-03 | 1.83 |
| 2025-07-04 | 1.82 |
| 2025-04-04 | 2.36 |
| 2025-01-03 | 2.50 |
| 2024-09-27 | 1.97 |
| 2024-06-28 | 1.89 |
| 2024-03-29 | 2.37 |
| 2023-12-29 | 2.37 |
| 2023-09-30 | 2.34 |
| 2023-06-30 | 2.15 |
| 2023-03-31 | 1.96 |
| 2022-12-30 | 1.82 |
| 2022-09-30 | 1.77 |
| 2022-07-01 | 1.70 |
| 2022-04-01 | 1.80 |
| 2021-12-31 | 2.07 |
| 2021-09-30 | 1.98 |
| 2021-07-02 | 1.70 |
| 2021-04-02 | 1.92 |
| 2021-01-01 | 1.66 |
| 2020-09-30 | 1.56 |
| 2020-07-03 | 1.12 |
| 2020-04-03 | 0.87 |
| 2020-01-03 | 0.90 |
| 2019-09-30 | 1.09 |
| 2019-06-28 | 1.04 |
| 2019-03-29 | 1.13 |
| 2018-12-28 | 1.26 |
| 2018-09-30 | 1.46 |
| 2018-06-29 | 1.42 |
| 2018-03-30 | 1.46 |
| 2017-12-29 | 1.60 |
| 2017-09-30 | 1.72 |
| 2017-06-30 | 1.59 |
| 2017-03-31 | 1.46 |
| 2016-12-30 | 2.25 |
| 2016-09-30 | 2.09 |
| 2016-06-30 | 1.97 |
| 2016-03-31 | 0.00 |
| 2015-12-31 | 0.00 |
| 2015-09-30 | 1.80 |